# Enteral Omega 3 During Radiotherapy to Improve the Quality of Life and Functionality of Head and Neck Cancer Patients

> **NCT03720158** · NA · TERMINATED · sponsor: **Coordinación de Investigación en Salud, Mexico** · enrollment: 9 (actual)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma
- Quality of Life
- Radiotherapy; Complications

## Interventions

- **DIETARY_SUPPLEMENT:** Omega 3 Group
- **DIETARY_SUPPLEMENT:** Placebo or Control Group

## Key facts

- **NCT ID:** NCT03720158
- **Lead sponsor:** Coordinación de Investigación en Salud, Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-10-10
- **Primary completion:** 2021-07-31
- **Final completion:** 2021-07-31
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** The activities in the study hospital were seriously impacted by the medical care of COVID patients, affecting the medical management protocol of the study population. This situation does not allow to continue with the recruitment of patients.
- **Last updated:** 2022-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03720158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03720158, "Enteral Omega 3 During Radiotherapy to Improve the Quality of Life and Functionality of Head and Neck Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03720158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*